Literature DB >> 10408987

Positive predictive value of ICD-9th codes for upper gastrointestinal bleeding and perforation in the Sistema Informativo Sanitario Regionale database.

C Cattaruzzi1, M G Troncon, L Agostinis, L A García Rodríguez.   

Abstract

We identified patients whose records in the Sistema Informativo Sanitario Regionale database in the Italian region of Friuli-Venezia Giulia showed a code of upper gastrointestinal bleeding (UGIB) and perforation according to codes of the International Classification of Diseases (ICD)-9th revision. The validity of site- and lesion-specific codes (531 to 534) and nonspecific codes (5780, 5781, and 5789) was ascertained through manual review of hospital clinical records. The initial group was made of 1779 potential cases of UGIB identified with one of these codes recorded. First, the positive predictive values (PPV) were calculated in a random sample. As a result of the observed high PPV of 531 and 532 codes, additional hospital charts were solely requested for all remaining potential cases with 533, 534, and 578 ICD-9 codes. The overall PPV reached a high of 97% for 531 and 532 site-specific codes, 84% for 534 site-specific codes, and 80% for 533 lesion-specific codes, and a low of 59% for nonspecific codes. These data suggest a considerable research potential for this new computerized health care database in Southern Europe.

Entities:  

Mesh:

Year:  1999        PMID: 10408987     DOI: 10.1016/s0895-4356(99)00004-9

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  16 in total

1.  High-dimensional versus conventional propensity scores in a comparative effectiveness study of coxibs and reduced upper gastrointestinal complications.

Authors:  E Garbe; S Kloss; M Suling; I Pigeot; S Schneeweiss
Journal:  Eur J Clin Pharmacol       Date:  2012-07-05       Impact factor: 2.953

2.  Evaluating short-term drug effects using a physician-specific prescribing preference as an instrumental variable.

Authors:  M Alan Brookhart; Philip S Wang; Daniel H Solomon; Sebastian Schneeweiss
Journal:  Epidemiology       Date:  2006-05       Impact factor: 4.822

3.  Comparative gastrointestinal safety of weekly oral bisphosphonates.

Authors:  S M Cadarette; J N Katz; M A Brookhart; T Stürmer; M R Stedman; R Levin; D H Solomon
Journal:  Osteoporos Int       Date:  2009-03-06       Impact factor: 4.507

4.  Comment on: "Desideratum for evidence-based epidemiology".

Authors:  Sean Hennessy; Charles E Leonard
Journal:  Drug Saf       Date:  2015-01       Impact factor: 5.606

5.  The Role of Hemoglobin Laboratory Test Results for the Detection of Upper Gastrointestinal Bleeding Outcomes Resulting from the Use of Medications in Observational Studies.

Authors:  Elisabetta Patorno; Joshua J Gagne; Christine Y Lu; Kevin Haynes; Andrew T Sterrett; Jason Roy; Xingmei Wang; Marsha A Raebel
Journal:  Drug Saf       Date:  2017-01       Impact factor: 5.606

6.  Concurrent use of warfarin and antibiotics and the risk of bleeding in older adults.

Authors:  Jacques Baillargeon; Holly M Holmes; Yu-Li Lin; Mukaila A Raji; Gulshan Sharma; Yong-Fang Kuo
Journal:  Am J Med       Date:  2012-02       Impact factor: 4.965

7.  The Validity of HCC Diagnosis Codes in Chronic Hepatitis B Patients in the Veterans Health Administration.

Authors:  Ronald Omino; Sahil Mittal; Jennifer R Kramer; Maneerat Chayanupatkul; Peter Richardson; Fasiha Kanwal
Journal:  Dig Dis Sci       Date:  2017-03-07       Impact factor: 3.199

8.  Association between weekend admission and mortality for upper gastrointestinal hemorrhage: an observational study and meta-analysis.

Authors:  Erin Renae Weeda; Brandon Scott Nicoll; Craig Ian Coleman; Anna Sharovetskaya; William Leslie Baker
Journal:  Intern Emerg Med       Date:  2016-08-17       Impact factor: 3.397

9.  Changing Epidemiology of Upper Gastrointestinal Hemorrhage in the Last Decade: A Nationwide Analysis.

Authors:  Brandon A Wuerth; Don C Rockey
Journal:  Dig Dis Sci       Date:  2017-12-27       Impact factor: 3.199

10.  Adverse gastrointestinal events with intravitreal injection of vascular endothelial growth factor inhibitors: nested case-control study.

Authors:  Robert J Campbell; Chaim M Bell; Susan E Bronskill; J Michael Paterson; Marlo Whitehead; Erica de L Campbell; Sudeep S Gill
Journal:  Drug Saf       Date:  2014-09       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.